JUNS — Jupiter Neurosciences Balance Sheet
0.000.00%
- $14.47m
- $15.98m
- $0.02m
Annual balance sheet for Jupiter Neurosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.331 | 0.064 | 0.028 | 3.77 | 3.79 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0 | — | — | 0.767 | 0.769 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.455 | 0.07 | 0.029 | 4.65 | 4.82 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.209 | 0.163 | 0.116 | 0.07 | 0.023 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.667 | 0.236 | 0.149 | 6.2 | 5.56 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5.68 | 7.26 | 5.77 | 2.01 | 7.4 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.85 | 7.38 | 5.95 | 2.03 | 7.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -5.18 | -7.14 | -5.8 | 4.17 | -1.83 |
| Total Liabilities & Shareholders' Equity | 0.667 | 0.236 | 0.149 | 6.2 | 5.56 |
| Total Common Shares Outstanding |